LekoskopLekoskop
UK · ES · FR · CS · IT · NL · CH · HR · PL

New approvals — United Kingdom — May 2026

MHRA medicines recalls and defect notifications with batch numbers, Serious Shortage Protocols, new approvals and Drug Safety Update — updated daily, automatically. Last updated: 27 Sep 2026 13:39.

All Recalls and defects2 Serious shortages (SSP)2 New approvals1 Drug Safety Update1
clear

Sources: we track changes based on information published by the MHRA — medicines recalls and defect notifications, Drug Safety Update and approval announcements — and the Serious Shortage Protocols published by the NHS Business Services Authority. The UK is outside the EU, so European Commission decisions are not listed here.

expand all dayscollapse all days

15 May 2026Friday 15 May 2026

open day ◀ ▶ 1 event
MHRA approval beremagene geperpavec (Vyjuvek)
As with any medicine, the MHRA will keep the safety and effectiveness of Vyjuvek under close review.
What this means, batches, details

Loading…

MHRA announcement ↗ MHRA — Medicines and Healthcare products Regulatory Agency

7 May 2026Thursday 7 May 2026

open day ◀ ▶ 1 event
MHRA approval donidalorsen (Dawnzera)
MHRA approves donidalorsen (Dawnzera) for the treatment of hereditary angioedema
What this means, batches, details

Loading…

MHRA announcement ↗ MHRA — Medicines and Healthcare products Regulatory Agency

1 May 2026Friday 1 May 2026

open day ◀ ▶ 1 event
MHRA approval Linerixibat (Lynavoy)
As with all medicines, we will continue to closely monitor the safety and effectiveness of linerixibat as it is used more widely.
What this means, batches, details

Loading…

MHRA announcement ↗ MHRA — Medicines and Healthcare products Regulatory Agency

In total 3 events in this category.